Lagos, Nigeria. The Board of Directors of PZ Cussons Nigeria Plc, a leading manufacturer of personal healthcare products and consumer goods, recorded N260.46 billion in revenue for the 2026 financial year, representing 22% growth, compared with N212.63 billion in the corresponding period in 2025.
The Board has proposed a dividend payment of N2.50k per share, subject to shareholders’ approval at the forthcoming Annual General Meeting holding 28 October 2026.
A breakdown analysis of the audited financial results for the year ended 31 May 2026, revealed that the company delivered strong performance with recurring operating profit rising by 117% to ₦37.1 billion.
In a statement issued by the Company Secretary, Oghenekevwe Ogefere, it was disclosed that the total operating profit rose to ₦77.1 billion, supported by improved underlying performance and non-recurring income, principally arising from scrap sales and gains on the disposal of non-core assets.
Ogefere stated that the performance reflects the commitment of the company’s people, continued investment in priority brands, product innovation, improved route-to-market execution, and disciplined cost management.
